The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract.
about
Functional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesisIntestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activityIdentification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesisMechanistic Insights into the Hydrolysis and Synthesis of Ceramide by Neutral CeramidaseSphingomyelin content of intestinal cell membranes regulates cholesterol absorption. Evidence for pancreatic and intestinal cell sphingomyelinase activitySubstrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controlsSelective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis.Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis.Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatographyCancer treatment strategies targeting sphingolipid metabolism.Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor γ expression.Crucial role of alkaline sphingomyelinase in sphingomyelin digestion: a study on enzyme knockout mice.Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation?Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.Impact of HIV-1 Membrane Cholesterol on Cell-Independent Lytic Inactivation and Cellular Infectivity.Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in miceRoles for biological membranes in regulating human immunodeficiency virus replication and progress in the development of HIV therapeutics that target lipid metabolism.Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.Uptake of the glycosphingolipid sulfatide in the gastrointestinal tract and pancreas in vivo and in isolated islets of LangerhansA simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease.Intestinal absorption of dietary maize glucosylceramide in lymphatic duct cannulated rats.The intestinal brush border.Preparation of (13)C-labeled ceramide by acetic acid bacteria and its incorporation in miceStudies on the phospholipases of rat intestinal mucosa.Alkaline sphingomyelinase (NPP7) in hepatobiliary diseases: A field that needs to be closely studied.
P2860
Q24528157-18667298-D86B-40F4-9975-D82E63603320Q24541516-C77BC717-A816-4559-B04E-69C9E0EEDD94Q24653460-95C7ABB2-0D4E-4667-BC23-CAEE1F542295Q27653166-E45F0B0C-3F45-47A8-A3D7-DDBF116CDB46Q28316989-FF33DB52-6047-4CCD-A6C3-3222CDF773EAQ28367380-0737A49E-5849-440A-A43F-3CFF66C37CFCQ30524346-8B92C82C-AE2A-447B-BE24-FCAD3A47306DQ33357486-D803EC3E-9C19-4D41-9FDC-0086D3C00278Q34007818-A7BD07BA-81E2-4386-960B-DF65DBE3A3B7Q34078002-96D25526-7B90-42F1-9749-5E98E3E64C6DQ34790629-020C964B-526C-4599-AC00-2D744810A97DQ35103261-CD07FF40-A6EE-4E12-A4C6-95EBCFC35E67Q35771158-D419D50E-066D-4359-B47B-ECB93BE52FC8Q36619585-2646525D-1E02-42BB-BC43-4DFDE5DC518CQ36861002-D530D4E9-5CC6-456A-A0A0-A3B1188C6FC2Q37183472-603ACD65-562E-49B8-B781-D18A24FE2E17Q37391027-D10AFEB1-D3D5-4E4A-9F97-8AFF44F9240FQ37858901-160FF2E1-19C5-4316-8EEF-17FA04245F7BQ37880161-D7E47C9B-53B1-42F3-8ABC-04E3B445C800Q38841620-35A70C18-97DA-4F15-AB6C-73A54BFB1BC2Q39651519-435228DA-D5C7-45FE-A982-1701C154D8F2Q40948826-D17B847B-7A79-4C8D-980D-79CB7B20B907Q41786358-B707609F-9F57-4D18-B7F1-204C75E6D74CQ41833396-89372D10-0719-4948-880A-FE90757FCB33Q41871964-3827984D-478B-4E95-AD50-7399565828C4Q54937330-73BFF45E-537E-4A96-9FB6-59B6DE414A3B
P2860
The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract.
description
1969 nî lūn-bûn
@nan
1969 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1969 թվականի մարտին հրատարակված գիտական հոդված
@hy
1969年の論文
@ja
1969年論文
@yue
1969年論文
@zh-hant
1969年論文
@zh-hk
1969年論文
@zh-mo
1969年論文
@zh-tw
1969年论文
@wuu
name
The presence of spingomyelin- ...... in the small intestinal tract.
@ast
The presence of spingomyelin- ...... in the small intestinal tract.
@en
The presence of spingomyelin- ...... in the small intestinal tract.
@nl
type
label
The presence of spingomyelin- ...... in the small intestinal tract.
@ast
The presence of spingomyelin- ...... in the small intestinal tract.
@en
The presence of spingomyelin- ...... in the small intestinal tract.
@nl
prefLabel
The presence of spingomyelin- ...... in the small intestinal tract.
@ast
The presence of spingomyelin- ...... in the small intestinal tract.
@en
The presence of spingomyelin- ...... in the small intestinal tract.
@nl
P1476
The presence of spingomyelin- ...... in the small intestinal tract.
@en
P2093
P304
P407
P577
1969-03-01T00:00:00Z